Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma von Pacenta, Holly L, Macy, Margaret E

Volltext

Bevacizumab as Therapy for Radiation Necrosis in Four Children With Pontine Gliomas von Liu, Arthur K., M.D., Ph.D, Macy, Margaret E., M.D, Foreman, Nicholas K., M.R.C.P

Volltext

Model‐informed approach to support pediatric dosing for the pan‐PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors von Morcos, Peter N., Schlender, Jan, Burghaus, Rolf, Moss, Jonathan, Lloyd, Adam, Childs, Barrett H., Macy, Margaret E., Reid, Joel M., Chung, John, Garmann, Dirk

Volltext

Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology, and End Results Analysis Validating COG Risk Stratifications von Waxweiler, Timothy V., MD, Rusthoven, Chad G., MD, Proper, Michelle S., MD, Cost, Carrye R., MD, Cost, Nicholas G., MD, Donaldson, Nathan, DO, Garrington, Timothy, MD, Greffe, Brian S., MD, Heare, Travis, MD, Macy, Margaret E., MD, Liu, Arthur K., MD, PhD

Volltext

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an op... von Geoerger, Birgit, Kang, Hyoung Jin, Yalon-Oren, Michal, Marshall, Lynley V, Vezina, Catherine, Pappo, Alberto, Laetsch, Theodore W, Petrilli, Antonio S, Ebinger, Martin, Toporski, Jacek, Glade-Bender, Julia, Nicholls, Wayne, Fox, Elizabeth, DuBois, Steven G, Macy, Margaret E, Cohn, Susan L, Pathiraja, Kumudu, Diede, Scott J, Ebbinghaus, Scot, Pinto, Navin

Volltext

A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML von Gore, Lia, Triche, Jr, Timothy J, Farrar, Jason E, Wai, Daniel, Legendre, Christophe, Gooden, Gerald C, Liang, Winnie S, Carpten, John, Lee, David, Alvaro, Frank, Macy, Margaret E, Arndt, Carola, Barnette, Philip, Cooper, Todd, Martin, Laura, Narendran, Aru, Pollard, Jessica, Meshinchi, Soheil, Boklan, Jessica, Arceci, Robert J, Salhia, Bodour

Volltext

Opportunities and Challenges in Drug Development for Pediatric Cancers von Laetsch, Theodore W, DuBois, Steven G, Bender, Julia Glade, Macy, Margaret E, Moreno, Lucas

Volltext

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG) von Desai, Ami V, Robinson, Giles W, Gauvain, Karen, Basu, Ellen M, Macy, Margaret E, Maese, Luke, Whipple, Nicholas S, Sabnis, Amit J, Foster, Jennifer H, Shusterman, Suzanne, Yoon, Janet, Weiss, Brian D, Abdelbaki, Mohamed S, Armstrong, Amy E, Cash, Thomas, Pratilas, Christine A, Corradini, Nadège, Marshall, Lynley V, Farid-Kapadia, Mufiza, Chohan, Saibah, Devlin, Clare, Meneses-Lorente, Georgina, Cardenas, Alison, Hutchinson, Katherine E, Bergthold, Guillaume, Caron, Hubert, Chow Maneval, Edna, Gajjar, Amar, Fox, Elizabeth

Volltext

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results von Goldsmith, Kelly C., Park, Julie R., Kayser, Kimberly, Malvar, Jemily, Chi, Yueh-Yun, Groshen, Susan G., Villablanca, Judith G., Krytska, Kateryna, Lai, Lillian M., Acharya, Patricia T., Goodarzian, Fariba, Pawel, Bruce, Shimada, Hiroyuki, Ghazarian, Susan, States, Lisa, Marshall, Lynley, Chesler, Louis, Granger, Meaghan, Desai, Ami V., Mody, Rajen, Morgenstern, Daniel A., Shusterman, Suzanne, Macy, Margaret E., Pinto, Navin, Schleiermacher, Gudrun, Vo, Kieuhoa, Thurm, Holger C., Chen, Joseph, Liyanage, Marlon, Peltz, Gerson, Matthay, Katherine K., Berko, Esther R., Maris, John M., Marachelian, Araz, Mossé, Yael P.

Volltext

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma von DuBois, Steven G, Mosse, Yael P, Fox, Elizabeth, Kudgus, Rachel A, Reid, Joel M, McGovern, Renee, Groshen, Susan, Bagatell, Rochelle, Maris, John M, Twist, Clare J, Goldsmith, Kelly, Granger, M Meaghan, Weiss, Brian, Park, Julie R, Macy, Margaret E, Cohn, Susan L, Yanik, Greg, Wagner, Lars M, Hawkins, Randall, Courtier, Jesse, Lai, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Boucher, Najee, Czarnecki, Scarlett, Luo, Chunqiao, Tsao-Wei, Denice, Matthay, Katherine K, Marachelian, Araz

Volltext

Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial von Loeb, David M., Lee, Ji Won, Morgenstern, Daniel A., Samson, Yvan, Uyttebroeck, Anne, Lyu, Chuhl Joo, Van Damme, An, Nysom, Karsten, Macy, Margaret E., Zorzi, Alexandra P., Xiong, Julia, Pollert, Petra, Joerg, Ingrid, Vugmeyster, Yulia, Ruisi, Mary, Kang, Hyoung Jin

Volltext

Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-... von Lerman, Benjamin J, Li, Yimei, Carlowicz, Cecilia, Granger, Meaghan, Cash, Thomas, Sadanand, Arhanti, Somers, Katherine, Ranavaya, Aeesha, Weiss, Brian D, Choe, Michelle, Foster, Jennifer H, Pinto, Navin, Morgenstern, Daniel A, Rafael, Margarida Simão, Streby, Keri A, Zeno, Rachel N, Mody, Rajen, Yazdani, Sahr, Desai, Ami V, Macy, Margaret E, Shusterman, Suzanne, Federico, Sara M, Bagatell, Rochelle

Volltext

Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer von Church, Alanna J., Corson, Laura B., Kao, Pei-Chi, Imamovic-Tuco, Alma, Reidy, Deirdre, Doan, Duong, Kang, Wenjun, Pinto, Navin, Maese, Luke, Laetsch, Theodore W., Kim, AeRang, Colace, Susan I., Macy, Margaret E., Applebaum, Mark A., Bagatell, Rochelle, Sabnis, Amit J., Weiser, Daniel A., Glade-Bender, Julia L., Homans, Alan C., Hipps, John, Harris, Haley, Manning, Danielle, Al-Ibraheemi, Alyaa, Li, Yvonne, Gupta, Hersh, Cherniack, Andrew D., Lo, Ying-Chun, Strand, Gianna R., Lee, Lobin A., Pinches, R. Seth, Lazo De La Vega, Lorena, Harden, Maegan V., Lennon, Niall J., Choi, Seong, Comeau, Hannah, Harris, Marian H., Forrest, Suzanne J., Clinton, Catherine M., Crompton, Brian D., Kamihara, Junne, MacConaill, Laura E., Volchenboum, Samuel L., Lindeman, Neal I., Van Allen, Eliezer, DuBois, Steven G., London, Wendy B., Janeway, Katherine A.

Volltext

A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic... von Cooper, Todd M., Sison, Edward Allan Racela, Baker, Sharyn D., Li, Lie, Ahmed, Amina, Trippett, Tanya, Gore, Lia, Macy, Margaret E., Narendran, Aru, August, Keith, Absalon, Michael J., Boklan, Jessica, Pollard, Jessica, Magoon, Daniel, Brown, Patrick A.

Volltext

Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer von Pearson, Andrew DJ, DuBois, Steven G., Macy, Margaret E., de Rojas, Teresa, Donoghue, Martha, Weiner, Susan, Knoderer, Holly, Bernardi, Ronald, Buenger, Vickie, Canaud, Guillaume, Cantley, Lewis, Chung, John, Fox, Elizabeth, Friend, John, Glade-Bender, Julia, Gorbatchevsky, Igor, Gore, Lia, Gupta, Abha, Hawkins, Douglas S., Juric, Dejan, Lang, Leigh Anna, Leach, Danielle, Liaw, Danny, Lesa, Giovanni, Ligas, Franca, Lindberg, Gavin, Lindberg, Wendy, Ludwinski, Donna, Marshall, Lynley, Mazar, Andrew, McDonough, Joe, Nysom, Karsten, Ours, Christopher, Pappo, Alberto, Parsons, D.William, Rosenfeld, Amy, Scobie, Nicole, Smith, Malcolm, Taylor, Danielle, Weigel, Brenda, Weinstein, Amy, Karres, Dominik, Vassal, Gilles

Volltext

Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Insti... von Park, Julie R., Villablanca, Judith G., Hero, Barbara, Kushner, Brian H., Wheatley, Keith, Beiske, Klaus H., Ladenstein, Ruth L., Baruchel, Sylvain, Macy, Margaret E., Moreno, Lucas, Seibel, Nita L., Pearson, Andrew D., Matthay, Katherine K., Valteau‐Couanet, Dominique

Volltext

Experience with ponatinib in paediatric patients with leukaemia von Rossoff, Jenna, Huynh, Van, Rau, Rachel E., Macy, Margaret E., Sulis, Maria L., Schultz, Kirk R., Burke, Michael J., Athale, Uma, O'Brien, Maureen M., Gregory, John J., Sluis, Inge M., Keller, Frank G., Zwaan, Christian M., Suttorp, Meinolf, Hijiya, Nobuko

Volltext

Bevacizumab in the treatment of radiation injury for children with central nervous system tumors von Dahl, Nathan A., Liu, Arthur K., Foreman, Nicholas K., Widener, Melissa, Fenton, Laura Z., Macy, Margaret E.

Volltext

Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial von Pinto, Navin, DuBois, Steven G., Marachelian, Araz, Diede, Scott J., Taraseviciute, Agne, Glade Bender, Julia L., Tsao‐Wei, Denice, Groshen, Susan G., Reid, Joel M., Haas‐Kogan, Daphne A., Reynolds, C. Patrick, Kang, Min H., Irwin, Meredith S., Macy, Margaret E., Villablanca, Judith G., Matthay, Katherine K., Park, Julie R.

Volltext

High-Risk and Relapsed Neuroblastoma: Toward More Cures and Better Outcomes von DuBois, Steven G, Macy, Margaret E, Henderson, Tara O

Volltext